Delivery Order SPE2DB22D1106-SPE2DB25FESD1
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $1,856.40. This competitively awarded, firm fixed-price contract is scheduled for completion by August 12, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on June 2, 2025, with a ceiling value of $7,584.92 and an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The award represents a continuation of AmerisourceBergen's critical role in supplying pharmaceutical products and medical devices to support federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $14,125.92 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a standard pharmaceutical procurement supporting federal medical supply chain requirements. The place of performance is listed as...
- The Defense Logistics Agency awarded a $2,784.60 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector supplies (2-packs) on July 10, 2025, with completion targeted for July 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs under a firm fixed-price contract structure. The order, valued at $15,123.04, will be completed by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,533.52 and a completion date of September 18, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal supply arrangement. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,856.40 delivery order contract to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed price, competitively awarded delivery order is expected to be completed by September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order represents a task issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $1,595.49. This is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $2,724.24. This competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine procurement action under the pharmaceutical supply chain supporting federal medical needs,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FESD1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, valued at $1,427.30. This non-set-aside, firm fixed price delivery order is due for completion by June 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical and medical supply vendor to the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, medical devices, and healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's position as a prime pharmaceutical vendor reflects the company's demonstrated capability to meet federal medical procurement requirements and supply critical medications and emergency medical supplies across the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/6/25 |